Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan-Feb;6(1):55-60.
doi: 10.4103/2303-9027.200216.

Contrast-enhanced (endoscopic) ultrasound and endoscopic ultrasound elastography in gastrointestinal stromal tumors

Affiliations

Contrast-enhanced (endoscopic) ultrasound and endoscopic ultrasound elastography in gastrointestinal stromal tumors

Andre Ignee et al. Endosc Ultrasound. 2017 Jan-Feb.

Abstract

Background and objectives: Gastrointestinal stromal tumors (GISTs) represent the largest group of subepithelial tumors (SET) of the upper gastrointestinal (GI) tract. They may show malignant behavior, in contrast to other SET. Endoscopic ultrasound (EUS) is frequently used to characterize SET. With the introduction of contrast-enhanced ultrasound (CEUS) into EUS (CE-EUS), distinct enhancement patterns can be detected. In the presented study, the characteristic features of CE-EUS in GIST are analyzed and compared with those of other SET.

Materials and methods: Consecutive patients from four centers with SET of the upper and middle GI tract were included and received endoscopic or transcutaneous CEUS. The results were compared with EUS-guided tissue acquisition, forceps biopsy, or surgical resection.

Results: Forty-two out of 62 (68%) patients had SET of the stomach, 17/62 (27%) of the small intestine, 2/62 (3%) of the esophagus, and 1/62 (2%) extraintestinal. Eighty-one percent underwent surgery. Leiomyoma was found in 5/62 (8%) and GIST in 57/62 patients (92%). Thirty-nine out of 57 (68%) patients had GIST lesions in the stomach, 17/57 (30%) had GIST of the small intestine, and 1/57 (2%) patients had extraintestinal GISTs. GIST size was 62.6 ± 42.1 (16-200) mm. Hyperenhancement had a sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 98%, 100%, 100%, 93%, and 98% for the diagnosis of GIST. Fifty out of 57 patients with GIST (88%) showed avascular areas in the center of the lesions.

Conclusion: CE-EUS and CEUS show hyperenhancement and avascular areas in a high percentage of GIST but not in leiomyoma. Thus, GIST and leiomyoma can be discriminated accurately.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Typical enhancement pattern of leiomyoma; leiomyomas show frequently very low contrast uptake
Figure 2
Figure 2
Gastrointestinal stromal tumors in contrast-enhanced endoscopic ultrasound showing hypervascularization and displaying avascular areas
Figure 3
Figure 3
Gastrointestinal stromal tumors in contrast-enhanced endoscopic ultrasound showing less pronounced hypervascularization and displaying small avascular areas
Figure 4
Figure 4
Gastrointestinal stromal tumors in contrast-enhanced endoscopic ultrasound showing pronounced hypervascularization and displaying a tiny avascular area in the center

References

    1. Jenssen C, Barreiros AP, Will U, et al. German survey on EUS-Guided diagnosis and management of gastrointestinal stromal tumors (GISTs) – Evidence or “Gut-Feeling”? Ultraschall Med. 2015;36:494–500. - PubMed
    1. Choi YR, Kim SH, Kim SA, et al. Differentiation of large (>/= 5 cm) gastrointestinal stromal tumors from benign subepithelial tumors in the stomach: Radiologists’ performance using CT. Eur J Radiol. 2014;83:250–60. - PubMed
    1. Seo SW, Hong SJ, Han JP, et al. Accuracy of a scoring system for the differential diagnosis of common gastric subepithelial tumors based on endoscopic ultrasonography. J Dig Dis. 2013;14:647–53. - PubMed
    1. Kim GH, Kim KB, Lee SH, et al. Digital image analysis of endoscopic ultrasonography is helpful in diagnosing gastric mesenchymal tumors. BMC Gastroenterol. 2014;14:7. - PMC - PubMed
    1. Kim GH, Park DY, Kim S, et al. Is it possible to differentiate gastric GISTs from gastric leiomyomas by EUS? World J Gastroenterol. 2009;15:3376–81. - PMC - PubMed